Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02282774Phase 3Completed
Phase 3, randomised, double-blind trial of lidocaine and bupivacaine in postoperative pain (2 arms), sponsored by King Saud University. Primary endpoint: Time to first postoperative analgesic dose at 24 hours. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02282774.